Vertex, Inc. (NASDAQ: VERX) has announced plans to release its fourth quarter 2024 financial results on the morning of ...

Google might have just invested another billion dollars into Anthropic, who is one of the main rivals of OpenAI.

A Waltham biotech focused on cystic fibrosis and a Boston biotech led by serial founder Gary Glick are the first ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 10:30 AM ETCompany ParticipantsDr.

Indeed the largest M&A deal of 2024 was Vertex Pharmaceuticals’ acquisition ... the $43 billion shelled out by Pfizer for Seagen in 2023’s priciest buyout. However, the volume of biopharma ...

Furthermore, a 2023 report by Strategy& Middle East ... signed a memorandum of understanding with American giant Vertex Pharmaceuticals to enhance the biotechnology sector by localizing gene therapy ...

Whether balancing work commitments, personal appointments, or family events, a reliable calendar app can keep everything in order. Luckily, iOS and Android offer a variety of excellent calendar ...

Vertex (VERX – Research Report) received a Hold rating and price target from Raymond James analyst Alexander Sklar today. The company’s shares closed yesterday at $53.20. Discover the latest ...

T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics are part of the Zacks top Analyst Blog. Today's Research Daily features new research reports on 16 major stocks ...

The Mail and Calendar apps are now past their end-of-support deadline (December 31, 2024), and they could stop working at any moment. It’s been over six months since Microsoft announced that it ...

Here's what research says about the benefits and drawbacks of sleeping alongside your kids and partners.